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Background
Brazil is a country of Portuguese colonization with mas-
sive numbers of immigrants and Portuguese descendants
(25 millions). At least half of all Brazilian Y chromo-
somes are from Portuguese origin. Nevertheless, this
population suffered miscegenation with native Indians
and African descendants. African descendants Brazilians
have 48% of non-African genes, probably from Portu-
guese ascendance. In a previous work from our center a
common haplotype was demonstrated in Portuguese
and Brazilian patients from 22 families and the calcula-
tion of the most recent common ancestor in 13 families
demonstrated that it has occurred at 26 past generations
about 650 years ago hence before the time of Brazil’s
discovery (1500) [1]. The objective of this work is to
characterize demographic and clinical aspects of Brazi-
lian patients presenting with ATTR in light of the clear
Portuguese origin of the cases in a background of misce-
genation and heterogeneity of the population.
Methods
Baseline clinical and demographics aspects of Brazilian
patients included into THAOS (Transthyretin Amyloi-
dosis Outcomes Survey) patient registry were extracted
from 2007 to January 2015 in a total of 148 patients
(68 women and 80 men).
Results
Val30MetTTR mutation was found in 91.9% of the
cases. Other mutations included Ile107Val, Val122Ile,
Ala19Asp and Gly53Glu. The mean age at onset of dis-
ease was 37 years for men and 35 years for women.
Mean time from onset of symptoms to diagnosis was
5.9 years (median 3.3 years). 93.9% informed a family
history with more than 90% of Portuguese origin and
69% with aspects from Caucasian ethnicity. In 23% of
the cases, the diagnosis in family members was based on
clinical suspicion only. Amyloid deposit was found in
80% of the biopsies performed (34% salivary gland, 38%
nerve and 3.7 cardiac). Misdiagnosis was noticed in
27.4% of the cases (26% of Val30Met mutations and
37.5% of non Val30 Met mutations cases) with CIDP
being the most common. 25% of the patients took more
than 1 year to have their correct diagnosis. From 117
symptomatic patients 79.5% presented with motor neu-
ropathy (78% Val30 Met and 87.5% non-Val30Met);
85.5% presented with sensory neuropathy (85% Val30
Met and 87.5% non-Val30Met); 93% presented with
autonomic neuropathy (93.6% Val30 Met and 87.5%
non-Val30Met); 80.3% presented with gastrointestinal
complaints. Unintentional weight loss was present in
50% of the cases. 80.6% of early onset cases presented
with a motor neuropathy and 78.3% of late onset. Corre-
sponding numbers for sensory neuropathy were 87%
and 82.6%; and 94.6% and 87% for autonomic neuropa-
thy. Cardiac disorders were noted in 35.9% of the cases
(33.9% Val30 Met and 62.5% non-Val30Met 33.9%)
(NYHA 1 or > in 3% of patients with early onset and
17.4% of late onset). ECG abnormalities were found in
56% of the cases (71% being conduction abnormalities).
Left ventricular septum > 10 mm was seen in only 25%
of the cases.
Conclusion
The population was mostly characterized by early onset
TTR Val30Met neuropathic phenotype presentation, with
several cases also featuring some degree of cardiac disease,
very similar to cases from endemic regions of Portugal
even after several generations from the original immigra-
tion and a very important mixed racial population.1Federal University of Rio de Janeiro, CEPARM. Neurology, 21941913, Rio de
Janeiro, Brazil
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